Journals / Erciyes Medical Journal / 2019 / Cilt: 41 - Sayı: 4

Role of Cytology in Pleural Effusion: A Single-Center Experience

Pages
409–413
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that the contribution of repeated cytological examination of a material to diagnosis was approximately 3%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: As a fast and effective method, cytopathological examination of the pleural fluid is the diagnostic tool of choice in determining the etiology of a spectrum of inflammatory to neoplastic conditions.
📊
Key Findings & Data:Materials and Methods: Cytological materials of 433 patients with pleural effusion (PE) were retrospectively analyzed.
💡
Conclusion & Impact:It was found that the contribution of repeated cytological examination of a material to diagnosis was approximately 3%.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: As a fast and effective method, cytopathological examination of the pleural fluid is the diagnostic tool of choice in determining the etiology of a spectrum of inflammatory to neoplastic conditions. The aim of the present study was to investigate the role of pleural cytology samples examined within a certain time period in determining the presence of malignant cells. Materials and Methods: Cytological materials of 433 patients with pleural effusion (PE) were retrospectively analyzed. Clinical parameters and cytological diagnosis were recorded in consecutive patients with PE. Results: Of the 433 cases enrolled in the study, 264 (61%) were male, and 169 (39%) were female. 15.6% (67/433) of the cases were reported as malignant, and 85% were aged >50 years. It was found that the contribution of repeated cytological examination of a material to diagnosis was approximately 3%. The sensitivity and specificity of the cytological method were calculated as 34% and 99%, respectively. Immunocytochemistry was performed in 50 patients who received cell-block techniques, and 42.4% of those were diagnosed as malignant. Molecular tests were also performed in 5 patients. Conclusion: Although the sensitivity is low, cytological examination of the pleura can be considered a diagnostic tool of vital importance, especially in patients with an advanced-stage disease and poor performance, who can benefit from rapidly evolving and changing treatment options.

🔖

Cite This Article

SADULLAHOĞLU, C., UZUN, R. (2019). Role of Cytology in Pleural Effusion: A Single-Center Experience. Erciyes Medical Journal, Cilt: 41 - Sayı: 4, 409–413. https://ajindex.com/articles/175609

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. McGrath EE, Anderson PB. Diagnosis of pleural effusion: a systematic approach. Am J Crit Care 2011; 20(2): 119–27
  2. Cibas ES. Pleural, pericardial and peritoneal fluids. In: Cibas ES, Ducatman BS, editors. Cytopathology; diagnostic principle and clinical correlates. China: Elsevier; 2009. p 129-153
  3. Bibbo M, Draganova-Tacheva R, Naylor B. Plevral, peritoneal and pericardial effusions. In: Bibbo M, Wilbur DC, editors. Comprehensive cytopathology. China: Elsevier; 2015. p 403–48
  4. Herrera Lara S, Femandez-Fabrellas E, Juan Samper G, Marco Buades J, Andreu Lapiedra R, Pinilla Moreno A, et al. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters. Lung 2017; 195(5): 653–60
  5. Johnston WW. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 1985; 56(4): 905–9
  6. American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000;162(5):1987–2001
  7. Loveland P, Christie M, Hammerschlag G, Irving L, Steinfort D. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience. Intern Med J 2018; 48(11): 1318–24
  8. Hsu C. Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients. Diagn Cytopathol 1987; 3(l): 8–12
  9. Assawasaksakul T, Boonsarngsuk V, Incharoen P. A comparative study of conventional cytology and cell block method in the diagnosis of pleural effusion. J Thorac Dis 2017; 9(9): 3161–7
  10. Sundling KE, Cibas ES. Ancillary studies in pleural, pericardial, and peritoneal effusion cytology. Cancer Cytopathol 2018; 126(Suppl 8): 590–8
  11. Porcel JM. Biomarkers in the diagnosis of pleural diseases: a 2018 update. Ther Adv Respir Dis 2018; 12: 1753466618808660
  12. Rodriguez EF, Chowsilpa S, Maleki Z. The Differential Diagnosis in Nonlymphoproliferative Malignant Pleural Effusion Cytopathology and Its Correlation with Patients Demographics. Acta Cytol 2018; 62(5-6): 436–42
  13. Cakmak M, Durkan A. Analysis of patients with malignant and paramalignant pleural effusion. Bimed Res 2017; 28(5): 2226–9
  14. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J, et al. Management of malignant pleural effusions. Eur Respir J 2001; 18(2): 402–19
  15. Porcel JM, Quirós M, Gatius S, Bielsa S. Examination of cytological smears and cell blocks of pleural fluid: Complementary d